CCM Workshop

Saturday, December 11, 2021
Houston, Texas
30-Day Post-Meeting Survey

Name*
First Last
Email*
(Please ensure that this is the email used for registration.)
The knowledge or skills gained from the workshop have been applied to my clinical practice.*
- Yes
- No
- Not yet

As a result of participating in this workshop, please rate the degree to which you are now able to…*

	Excellent	Good	Satisfactory	Fair	Poor	N/A
Recognize the importance, benefits, challenges, and practical concerns regarding the interdisciplinary team approach for management of patients with spasticity, in order to develop individualized treatment plans
Interpret the clinical evidence, guidelines, and recommendations on the use of neurotoxins and adjunctive rehabilitation interventions (physical therapy [PT]/occupational therapy [OT]/speech-language pathology [SLP]), both alone and in combination, in order to establish appropriate treatment strategies for these patients
Assess neuromuscular pathology and individual patient functional goals, in order to identify appropriate muscles, determine dosing, maximize therapeutic benefit, and minimize complications
Evaluate methods of guidance and localization (ie, EMG, E-Stim, ultrasound), in order to incorporate best practices for proper placement of neurotoxin
Apply optimal guidance and localization techniques, especially ultrasound technology, in order to improve efficacy in injecting BoNT for treatment of spasticity
Integrate home exercise programs into spasticity management post-BoNT, in order to optimize patient rehabilitation outcomes
Facilitate interaction and improve communication among members of the interdisciplinary treatment team, in order to encourage appropriate referrals for both neurotoxin injection and adjunctive therapy that may optimize patient outcomes

Please review the case below and answer the questions that follow.
(Please be sure to complete this item before continuing with the survey)

45-year-old male who suffered a stroke 2 years before
Her exam is notable for the following:
- Excessive salivation affecting speech intelligibility
- Coughing up of secretions
He has recently received botulinum neurotoxin injections into the parotid and submandibular glands and has been referred to you for post-injection evaluation and therapy.
What assessments would you conduct before performing speech or swallowing therapy?*
What speech or swallowing interventions would you perform?*
Please describe when and how you might recommend incorporating adjunctive therapies (OT, PT) into the post-neurotoxin treatment plan for the management of this patient.*
How often do you receive referrals for post-injection therapy in this type of patient?*
- Never
- Occasionally
- Frequently
- Very Frequently
How often do you refer patients with spasticity and related speech, language, or swallowing disorders to physicians for consideration of neurotoxin injections?*
- Never
- Occasionally
- Frequently
- Very Frequently
How do you most efficiently manage communications with other members of the patient’s treatment team?*
As a result of this workshop, I have implemented changes in my practice in the following areas:*
Overall Evaluation
Yes No
Clinician-Patient Communication
Documentation (appropriate)
Patient Education
Clinician-Clinician Communication
Quality Improvement
Patient Safety
Treatment Approach

Did you change your practice by implementing the workshop’s recommended management strategies, and if so, how quickly after?*

	Yes, within 11-14 days	Yes, within 15-31 days	No, not yet	N/A
Utilized more refined screening criteria to identify patients for neurotoxin treatment
Referred patients where appropriate for neurotoxin treatment
Recommended or prescribed PT/OT/SLP where indicated for patients receiving neurotoxin treatment
Used routine outcome measurements (eg, Modified Ashworth Scale) more often or more consistently
Established or strengthened case documentation shared by treatment team members
Formed or expanded a treatment team of interdisciplinary members for case management
Shared workshop course materials with clinicians who did not participate in this workshop
More often or more consistently discussed with patients the importance of home exercise therapy as an adjunct to their clinical care

I have implemented the following specific change in my practice.
Please describe at least one clinical outcome in a specific patient case that you achieved or improved based on the skills and knowledge you developed in this workshop (please include HIPAA-/patient confidentiality–compliant patient descriptions):
Are there any specific lectures/topics that you would like covered at future workshops?
What is your specialty focus?*
- Neurology
- Physiatry
- Occupational Therapy
- Physical Therapy
- Speech-Language Pathology
- Other
Please specify your specialty focus*
Type of practice:*
- Hospital Setting
- Long-term Care/Skilled Nursing Facility
- Early Intervention Service
- Private Practice/office based
- School Health Program
- Academic Institution
- Outpatient Clinic
- Home Health Care
- Other
Please specify your type of practice*

	Yes	No
Clinician-Patient Communication
Documentation (appropriate)
Patient Education
Clinician-Clinician Communication
Quality Improvement
Patient Safety
Treatment Approach

Login

CCM Workshop

Saturday, December 11, 2021Houston, Texas30-Day Post-Meeting Survey

Saturday, December 11, 2021
Houston, Texas
30-Day Post-Meeting Survey